Search

Your search keyword '"Collée, J.M. (Margriet)"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Collée, J.M. (Margriet)" Remove constraint Author: "Collée, J.M. (Margriet)"
35 results on '"Collée, J.M. (Margriet)"'

Search Results

1. Long-term morbidity and health after early menopause due to oophorectomy in women at increased risk of ovarian cancer: Protocol for a nationwide cross-sectional study with prospective follow-up (HARMOny Study)

2. Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making

3. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

4. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

5. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

6. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

7. Online decision support for persons having a genetic predisposition to cancer and their partners during reproductive decision-making

8. The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study

9. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk

10. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

11. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

12. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

13. Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

14. Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

15. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

16. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

17. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

18. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

19. Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

20. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

21. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

22. MicroRNA related polymorphisms and breast cancer risk

23. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

24. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

25. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: Not only psychopathology matters

26. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

27. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

28. Rare variants in XRCC2 as breast cancer susceptibility alleles

29. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

30. Comparison of 6q25 breast cancer hits from Asian and European genome wide association studies in the Breast Cancer Association consortium (BCAC)

31. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

32. Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families

33. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

34. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

35. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

Catalog

Books, media, physical & digital resources